The Combination of Adductor Canal Block and Periarticular Injection. A Novel Technique for Patients Undergoing Total Knee Replacement (ACB PAI)
Source: ClinicalTrials.gov NCT02292082 ↗No peer-reviewed publication reporting this trial's results has been linked yet. This can indicate results are unpublished — a known publication-bias signal. We re-check periodically.
Summary
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Time to Meet Physical Therapy Discharge Criteria |
2109.3; 1883.1 | — |
| SECONDARY Numerical Rating Scale (NRS) Pain Scores With Ambulation Postoperative Day 1 |
4.3; 3.9 | — |
| SECONDARY NRS Pain Score With Movement POD2 |
4.7; 5.2 | — |
| SECONDARY Opioid Consumption Postoperative Day (POD) 1 |
58.4; 47.5 | — |
| SECONDARY Opioid Consumption POD2 |
67.9; 60.1 | — |
| SECONDARY Hospital Length of Stay |
3491; 3394.4 | — |
| SECONDARY Patient Outcome Questionnaire (painOUT) Least Pain for 0-24 Hours Postoperatively |
1.5; 0.8 | — |
| SECONDARY Patient Outcome Questionnaire (painOUT) Least Pain for 24-48 Hours Postoperatively |
1.7; 1.8 | — |
| SECONDARY Patient Outcome Questionnaire (painOUT) Most Pain for 0-24 Hours Postoperatively |
6.7; 5.3 | — |
| SECONDARY Patient Outcome Questionnaire (painOUT) Most Pain for 24-48 Hours Postoperatively |
6.9; 6.6 | — |
| SECONDARY Knee Society Score (KSS) at 6 Weeks Postoperatively |
85.2; 75.2 | — |
Eligibility Criteria
Inclusion Criteria
- Patients with osteoarthritis scheduled for primary tricompartmental total knee arthroplasty with a participating surgeon
- Age 18 to 80 years
- Planned use of regional anesthesia
- Ability to follow study protocol
- English speaking (secondary outcomes include questionnaires validated in English only)
Exclusion Criteria
Hepatic or renal insufficiency Patients younger than 18 years old and older than 80 Patients intending to receive general anesthesia Patients planning to go to rehab post operatively Patients scheduled to go into the OR after 1 pm Allergy or intolerance to one of the study medications Patients with an ASA of IV Chronic gabapentin/pregabalin use (regular use for longer than 3 months) Chronic opioid use (taking opioids for longer than 3 months) Diabetes Patients on workers compensation or disability
Data sourced from ClinicalTrials.gov (NCT02292082). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.